Related Experiment Videos
Methadone analgesia in morphine-insensitive CXBK mice
A Chang1, D W Emmel, G C Rossi
1The Cotzias Laboratory of Neuro-Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
European Journal of Pharmacology
|August 1, 1998
Summary
Methadone and morphine have distinct analgesic mechanisms, despite both acting on mu-opioid receptors. This study highlights potential subtypes of mu-opioid receptors, impacting pain management strategies.
Area of Science:
- Pharmacology
- Neuroscience
- Pain Research
Background:
- Methadone is a potent opioid analgesic often classified as a mu-opioid due to similarities with morphine.
- Methadone's effects are antagonized by beta-funaltrexamine, a mu-opioid receptor-selective antagonist, supporting its mu-opioid classification.
- CXBK mice are insensitive to morphine but respond to methadone, suggesting differing receptor mechanisms.
Purpose of the Study:
- To investigate the distinct receptor mechanisms of methadone and morphine.
- To determine if methadone's analgesia is mediated by mu-opioid receptors in CXBK mice.
- To explore the possibility of multiple mu-opioid receptor subtypes.
Main Methods:
- Utilizing CXBK mice, which possess a deficient mu-opioid receptor.
- Administering methadone and morphine to assess analgesic responses.
- Employing the mu-opioid receptor antagonist beta-funaltrexamine to test for antagonism of methadone analgesia.
Main Results:
- CXBK mice exhibited normal responses to methadone, unlike their insensitivity to morphine.
- Beta-funaltrexamine successfully antagonized methadone analgesia in CXBK mice.
- These findings indicate that methadone acts via mu-opioid receptors, even in morphine-insensitive models.
Conclusions:
- Morphine and methadone employ distinct analgesic pathways.
- Methadone's action is mediated through mu-opioid receptors, but potentially distinct subtypes.
- The study provides evidence for the existence of multiple mu-opioid receptor subtypes, crucial for understanding opioid pharmacology.